EXOKERYX
LIVE

Serial Number

97680953

Owner

Exokeryx, Inc.

Attorney

John W. Olivo Jr.

First Use Date

Oct 13, 2021

Filing Date

Nov 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXOKERYX Trademark

Serial Number: 97680953

EXOKERYX is a trademark filed by Exokeryx, Inc. on November 16, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Exokeryx, Inc. (5 trademarks)

3030 Bunker Hill St.
San Diego, CA 92109

Entity Type: 03

Trademark Details

Filing Date

November 16, 2022

Registration Date

Not Registered

First Use Anywhere

October 13, 2021

First Use in Commerce

November 15, 2021

Goods & Services

Kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for in vitro diagnostic use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for clinical use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for medical purposes

Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, for scientific, non-medical, or medical research use; Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, and assays, conjugation chemistries, and chemical groups for scientific or medical research use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for scientific research

Filing History

EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jun 3, 2026 EXFB
DIVISIONAL PROCESSING COMPLETE
Mar 17, 2026 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 12, 2026 AITU
DIVISIONAL REQUEST RECEIVED
Feb 27, 2026 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Feb 27, 2026 ERTD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2025 REAP
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 24, 2025 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Dec 4, 2024 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Dec 4, 2024 GECD
ACTION CONTINUING FINAL - COMPLETED
Dec 4, 2024 CNCF
EX PARTE APPEAL-INSTITUTED
Nov 21, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 21, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 5, 2024 EXAF
NOTICE OF REVIVAL - E-MAILED
Oct 30, 2024 NREV
PETITION GRANTED - TTAB APPEAL FILED
Oct 30, 2024 PGTT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 11, 2024 EXAF
TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Oct 4, 2024 ERTP
INCOMPLETE PETITION NOTICE MAILED
Oct 2, 2024 PINM
TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Sep 19, 2024 ERTP
INCOMPLETE PETITION NOTICE MAILED
Aug 29, 2024 PINM
ASSIGNED TO PETITION STAFF
Aug 29, 2024 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2024 TROA
TEAS PETITION TO REVIVE RECEIVED
Jul 22, 2024 PROA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 19, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 19, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 19, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 12, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 12, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 12, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2022 NWOS
NEW APPLICATION ENTERED
Nov 21, 2022 NWAP